Schizophrenia News and Research

Latest Schizophrenia News and Research

Increased mortality in schizophrenia ‘not attributable to drug therapy’

The increased mortality risk observed among patients with severe psychiatric illness, including schizophrenia, does not seem to be attributable to use of psychopharmacologic therapy, study findings indicate.

4 Sep 2013

Research finding provides blueprint for understanding how the brain communicates with itself

During a normal conversation, your brain is constantly adjusting the volume to soften the sound of your own voice and boost the voices of others in the room.

4 Sep 2013

Genetic score backs schizophrenia spectrum

Researchers report that polygenic scores derived from one well-characterized cohort of schizophrenia patients correspond to clinical diagnostic categories in another.

3 Sep 2013

Researchers identify potential drug target to recover from jet lag, disruptions in circadian system

University of Notre Dame researchers, as part of a collaborative effort, have identified a protein that potentially could be a target for drugs that would help people recover faster from jet lag and better adjust their circadian rhythms during rotational shift work.

31 Aug 2013

Researchers develop model that completes bridge between cellular and human studies of schizophrenia

Schizophrenia is one of the most devastating neurological conditions, with only 30 percent of sufferers ever experiencing full recovery. While current medications can control most psychotic symptoms, their side effects can leave individuals so severely impaired that the disease ranks among the top ten causes of disability in developed countries.

31 Aug 2013

Schizophrenia genetics come into focus

A study in Nature Genetics illustrates the large impact of genetic variation on risk for schizophrenia.

30 Aug 2013

Potential drug target to treat depression and other mood disorders may lie in GABA neurons

A new drug target to treat depression and other mood disorders may lie in a group of GABA neurons (gamma-aminobutyric acid -the neurotransmitters which inhibit other cells) shown to contribute to symptoms like social withdrawal and increased anxiety, Penn Medicine researchers report in a new study in the Journal of Neuroscience.

30 Aug 2013

Heritability of severe mental illness may be underestimated

Around one in three children of parents with a severe mental illness – schizophrenia, bipolar disorder, or major depressive disorder – will develop such a disorder themselves by early adulthood, a meta-analysis has found.

29 Aug 2013

Negative symptoms ‘key to recovery’ in first-episode psychosis

The severity of negative symptoms in people with first-episode psychosis is a strong determinant of subsequent recovery, a long-term study has shown.

29 Aug 2013

Scientists develop method to generate functioning brain cells that produce myelin

Stem cell technology has long offered the hope of regenerating tissue to repair broken or damaged neural tissue. Findings from a team of UC Davis investigators have brought this dream a step closer by developing a method to generate functioning brain cells that produce myelin - a fatty, insulating sheath essential to normal neural conduction.

29 Aug 2013

Inflammatory status upregulated in first-episode schizophrenia

Patients with first-episode schizophrenia exhibit upregulation of key proinflammatory molecules, study findings show.

28 Aug 2013

Life Technologies announces end-to-end sequencing solution for whole human exome CNV analysis

Life Technologies Corporation today announced the first end-to-end sequencing solution for exon-level copy number variation analysis, which combines the Ion Reporter CNV data analysis workflow, the Ion AmpliSeq Exome Kit and the Ion Proton® System.

27 Aug 2013

Cannabis affects addiction processes in adolescent brain

The nature of the teenage brain makes users of cannabis amongst this population particularly at risk of developing addictive behaviors and suffering other long-term negative effects, according to researchers at the University of Montreal and New York's Icahn School of Medicine at Mount Sinai.

27 Aug 2013

tDCS for 15 days improves sleep and fatigue symptoms in patients with PPS

Of the 15 million people around the world who have survived poliomyelitis, up to 80% report progressive deteriorating strength and endurance many years after infection, a condition known as post-polio syndrome (PPS).

27 Aug 2013

Two Genomic Pathways Tagged For Roles In Schizophrenia

...

26 Aug 2013

Study identifies 22 locations in the human genome that cause schizophrenia

A new genome-wide association study estimates the number of different places in the human genome that are involved in schizophrenia.

26 Aug 2013

Loyola neurologists describe first known case of musical hallucinations

One night when she was trying to fall asleep, a 60-year-old woman suddenly began hearing music, as if a radio were playing at the back of her head. The songs were popular tunes her husband recognized when she sang or hummed them. But she herself could not identify them. This is the first known case of a patient hallucinating music that was familiar to people around her, but that she herself did not recognize, according to Dr. Danilo Vitorovic and Dr. José Biller of Loyola University Medical Center.

23 Aug 2013

Schizophrenia News and Research

Latest Schizophrenia News and Research

Increased mortality in schizophrenia ‘not attributable to drug therapy’

Research finding provides blueprint for understanding how the brain communicates with itself

Genetic score backs schizophrenia spectrum

Researchers identify potential drug target to recover from jet lag, disruptions in circadian system

Researchers develop model that completes bridge between cellular and human studies of schizophrenia

Schizophrenia genetics come into focus

Potential drug target to treat depression and other mood disorders may lie in GABA neurons

Heritability of severe mental illness may be underestimated

Negative symptoms ‘key to recovery’ in first-episode psychosis

Scientists develop method to generate functioning brain cells that produce myelin

Inflammatory status upregulated in first-episode schizophrenia

Life Technologies announces end-to-end sequencing solution for whole human exome CNV analysis

Cannabis affects addiction processes in adolescent brain

tDCS for 15 days improves sleep and fatigue symptoms in patients with PPS

Two Genomic Pathways Tagged For Roles In Schizophrenia

Study identifies 22 locations in the human genome that cause schizophrenia

Loyola neurologists describe first known case of musical hallucinations

Use of psychotherapy on a clear decline in US

Antipsychotic drugs for children with behavioral problems may put at risk for type 2 diabetes

Psychotic symptoms in people with schizophrenia caused by faulty 'switch' within brain

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Schizophrenia News and Research

Latest Schizophrenia News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in